Redcare Pharmacy NV (ETR:RDC)
Germany flag Germany · Delayed Price · Currency is EUR
64.45
+0.90 (1.42%)
Aug 4, 2026, 1:44 PM CET

Redcare Pharmacy NV Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Redcare Pharmacy NV stock has a consensus rating of "Buy" and an average price target of €86.10. The average 1-year stock price forecast is 33.59% higher than the current stock price, while the lowest is €55.00 (-14.66%) and the highest is €116.00 (+79.98%).

Price Target: €86.10 (+33.59%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price€55.00€86.10€85.00€116.00
Change-14.66%+33.59%+31.89%+79.98%

Analyst Ratings

The average analyst rating for Redcare Pharmacy NV stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy544445
Buy222222
Hold233333
Sell000000
Strong Sell000000
Total9999910

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Hold
Maintains
€60.00€74.00
HoldMaintains€60.00€74.00+14.82%Jul 31, 2026
Deutsche Bank
Deutsche Bank
Buy
Maintains
€102.00€103.00
BuyMaintains€102.00€103.00+59.81%Jul 31, 2026
Berenberg Bank
Berenberg Bank
Buy
Maintains
€92.00€94.00
BuyMaintains€92.00€94.00+45.85%Jul 30, 2026
Barclays
Barclays
Buy
Maintains
€85.00
BuyMaintains€85.00+31.89%Jul 30, 2026
Baader Bank
Baader Bank
Buy
Maintains
€85.00
BuyMaintains€85.00+31.89%Jul 29, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.41B
from 2.94B
Increased by 16.02%
Revenue Next Year
3.81B
from 3.41B
Increased by 11.66%
EPS This Year
-0.38
from -1.40
EPS Next Year
1.21
from -0.38
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.06B1.20B1.80B2.37B2.94B3.41B
Revenue Growth
9.53%13.58%49.36%31.79%24.06%16.02%
Gross Profit
266.80M331.79M440.38M545.80M663.10M760.71M
Gross Margin
25.16%27.55%24.48%23.02%22.55%22.30%
Operating Income
-32.25M-47.23M-3.79M-39.00M-20.10M21.65M
Net Income
-74.19M-77.65M-12.04M-45.50M-37.70M-12.96M
EPS
-----1.40-0.38
Free Cash Flow
4.22M-53.42M-7.65M-1.95M-90.50M-34.03M
No. Analysts
-----9
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High3.5B
Avg3.4B
Low3.3B

Revenue Growth

Revenue Growth202620272028
High
17.5%
Avg
16.0%
Low
13.0%

EPS Forecast

EPS202620272028
High-0.01
Avg-0.38
Low-0.67

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-